SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
STK39 |
STK39, SPAK: STE20/SPS1-related proline-alanine-rich protein kinase |
0.265 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
ERG |
ERG: Transcriptional regulator ERG |
APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
0.265 |
Evidence |
|
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
0.265 |
Evidence |
|
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
0.265 |
Evidence |
|
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
0.265 |
Evidence |
|
ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
0.265 |
Evidence |
|
EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
0.265 |
Evidence |
|
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
0.265 |
Evidence |
O
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
TACSTD1 |
TACSTD1, GA733-2, M1S2, M4S1, MIC18, TROP1: Tumor-associated calcium signal tran |
0.265 |
Evidence |
|
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
COBL |
IPI00329653 |
0.265 |
Evidence |
|
ZFP36 |
ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|
NFATC1 |
IPI00336007 |
ZNF318 |
ZNF318, HRIHFB2436: Zinc finger protein 318 |
0.265 |
Evidence |
|
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
BRD3 |
BRD3, KIAA0043, RING3L: Bromodomain-containing protein 3 |
0.265 |
Evidence |
|
GTF2F2 |
IPI00329767 |
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
0.265 |
Evidence |
|
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.265 |
Evidence |
|
CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.265 |
Evidence |
|
SNCB |
SNCB: Beta-synuclein |
STK39 |
STK39, SPAK: STE20/SPS1-related proline-alanine-rich protein kinase |
0.265 |
Evidence |
|
C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
0.265 |
Evidence |
|
TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
0.265 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.265 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.265 |
Evidence |
|
TRAFD1 |
TRAFD1, FLN29: TRAF-type zinc finger domain-containing protein 1 |
USP10 |
USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 |
0.265 |
Evidence |
|
CIITA |
CIITA, MHC2TA: MHC class II transactivator |
FUBP1 |
IPI00375441 |
0.265 |
Evidence |
|
CFB |
CFB, BF, BFD: Complement factor B precursor |
CFI |
CFI, IF: Complement factor I precursor |
0.265 |
Evidence |
|